Tatsuhiro Shibata Selected Research

Tatsuhiro Shibata Research Topics

Disease

101	Neoplasms (Cancer) 03/2022 - 12/2002
15	Carcinogenesis 04/2022 - 12/2002
11	Lung Neoplasms (Lung Cancer) 06/2015 - 04/2005
10	Ductal Carcinoma 09/2013 - 10/2009
9	Neoplasm Metastasis (Metastasis) 10/2022 - 10/2009
9	Adenocarcinoma of Lung 12/2020 - 09/2005
8	Breast Neoplasms (Breast Cancer) 04/2012 - 06/2004
7	Hepatocellular Carcinoma (Hepatoma) 10/2017 - 07/2003
6	Cholangiocarcinoma 10/2022 - 04/2014
6	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 08/2002
6	Carcinoma (Carcinomatosis) 12/2020 - 04/2010
6	Adenocarcinoma 11/2019 - 06/2003
5	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 12/2017
5	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 09/2015
5	Liver Neoplasms (Liver Cancer) 01/2018 - 07/2003
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 10/2004
4	Heart Failure 01/2022 - 01/2019
4	Sarcoma (Soft Tissue Sarcoma) 03/2020 - 01/2017
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 10/2005
3	Glioma (Gliomas) 01/2020 - 04/2015
3	Neuroendocrine Carcinoma 09/2019 - 08/2013
3	Stomach Neoplasms (Stomach Cancer) 04/2014 - 10/2009
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2022 - 01/2016
2	Germinoma 01/2022 - 01/2014
2	Melanoma (Melanoma, Malignant) 11/2021 - 03/2011
2	Esophageal Squamous Cell Carcinoma 10/2021 - 06/2004
2	Death (Near-Death Experience) 07/2021 - 12/2017
2	Ependymoma 01/2021 - 01/2021
2	Disease Progression 12/2020 - 01/2017
2	Liposarcoma 02/2020 - 12/2019
2	Myocardial Infarction 01/2020 - 12/2017
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2018 - 01/2017
2	Triple Negative Breast Neoplasms 06/2017 - 04/2012
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2017 - 03/2008
2	Gallbladder Neoplasms (Gallbladder Cancer) 09/2015 - 10/2008
2	Osteosarcoma (Osteogenic Sarcoma) 03/2012 - 07/2008
2	Lobular Carcinoma 07/2010 - 06/2004
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2009 - 11/2007
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2009 - 09/2008
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2006 - 11/2004

Drug/Important Bio-Agent (IBA)

16	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2005
15	Proteins (Proteins, Gene)FDA Link 10/2015 - 07/2003
9	Biological ProductsIBA 10/2017 - 08/2002
8	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2015
8	Phosphotransferases (Kinase)IBA 04/2014 - 10/2009
8	beta CateninIBA 11/2007 - 04/2002
6	Biomarkers (Surrogate Marker)IBA 11/2019 - 07/2007
6	ErbB Receptors (EGF Receptor)IBA 11/2007 - 09/2005
5	Anaplastic Lymphoma KinaseIBA 01/2019 - 10/2011
5	Messenger RNA (mRNA)IBA 01/2014 - 07/2003
4	Cadherins (E-Cadherin)IBA 10/2022 - 06/2004
4	Circulating Tumor DNAIBA 11/2021 - 12/2015
4	Small Interfering RNA (siRNA)IBA 10/2010 - 07/2008
3	Immune Checkpoint ProteinsIBA 03/2022 - 09/2015
3	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2021
3	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2021 - 04/2014
3	Estrogen ReceptorsIBA 01/2021 - 06/2009
3	Formaldehyde (Formol)FDA Link 01/2021 - 01/2018
3	ChromatinIBA 03/2020 - 05/2012
3	Cell-Free Nucleic AcidsIBA 01/2020 - 12/2015
3	Therapeutic UsesIBA 10/2019 - 01/2011
3	Bile Acids and Salts (Bile Acids)IBA 01/2019 - 10/2017
3	Pharmaceutical PreparationsIBA 02/2018 - 01/2014
3	Untranslated RNA (Noncoding RNA)IBA 12/2016 - 01/2014
3	EnzymesIBA 01/2016 - 06/2010
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2014 - 10/2009
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2014 - 10/2011
2	Deoxycholic Acid (Sodium Deoxycholate)IBA 04/2022 - 01/2019
2	Monoclonal AntibodiesIBA 01/2022 - 05/2014
2	Urethane (Ethyl Carbamate)IBA 01/2022 - 01/2016
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2017
2	NucleotidesIBA 01/2022 - 01/2018
2	AntigensIBA 01/2022 - 10/2015
2	Fluorouracil (Carac)FDA LinkGeneric 10/2021 - 10/2008
2	Opioid Analgesics (Opioids)IBA 07/2021 - 01/2020
2	ParaffinIBA 01/2021 - 01/2018
2	VimentinIBA 01/2021 - 01/2017
2	CrizotinibIBA 12/2020 - 01/2019
2	Keratins (Keratin)IBA 02/2020 - 01/2017
2	CytokinesIBA 01/2020 - 08/2007
2	hydrogen sulfite (bisulfite)IBA 01/2020 - 01/2018
2	Choline (Choline Chloride)IBA 12/2019 - 01/2019
2	Indicators and Reagents (Reagents)IBA 11/2019 - 09/2008
2	Genetic Markers (Genetic Marker)IBA 02/2018 - 01/2016
2	human ERBB2 proteinIBA 02/2018 - 06/2017
2	CarcinogensIBA 11/2016 - 10/2005
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016 - 01/2013
2	Gemcitabine FDA Link 06/2014 - 04/2010
2	dactolisibIBA 01/2014 - 11/2010
2	Hormones (Hormone)IBA 04/2012 - 07/2011
2	Codon (Codons)IBA 05/2011 - 11/2004
2	Gefitinib (Iressa)FDA Link 10/2006 - 10/2005

Therapy/Procedure

35	Therapeutics 03/2022 - 06/2009
6	Drug Therapy (Chemotherapy) 01/2022 - 10/2008
6	Neoadjuvant Therapy 04/2012 - 10/2009
4	Immunotherapy 03/2022 - 10/2015
4	Palliative Care (Palliative Therapy) 01/2022 - 01/2020
3	Transplantation 12/2020 - 10/2004
2	Terminal Care (Care, Terminal) 01/2022 - 07/2021
2	Radiotherapy 10/2021 - 07/2020